HemoCath is committed to improving healthcare for people living with heart failure.
Embedded Files
About HemoCath
About HemoCath
HemoCath Medical Ltd. is an Irish/US Digital Health & MedTech startup transforming heart failure (HF) care with the HemoDynamix™ AI platform — a novel scalable solution for the diagnosis, treatment, and monitoring of HF patients.
The platform combines the HemoCath™ PA catheter and the HemoDynamix™ AI cloud to turn continuous complex hemodynamic data into real-time clinical decisions — improving patient outcomes and reducing costs.
Leadership Team
Leadership Team
Our leadership team brings over 150 years of combined experience in medicine, engineering, commercialization, and corporate finance — with a proven record of turning breakthrough innovations into market successes.
Chris Glover, MD
CMO
Chris Glover, MD
CMO
Interventional Cardiologist,
Dir. Cardiac Catheterization Laboratory at University of Ottawa Heart Institute, Professor of Medicine, FRCPC
Eric Caron
CEO, Co-founder
Eric Caron
CEO, Co-founder
Entrepreneur and Engineer, Medtech / High-tech markets, Product dev. engineering, IP, Team building, Fundraising, Marketing and Sales. MBA
Des Regan
CTO, Co-founder
Des Regan
CTO, Co-founder
Medtech Engineer/Entrepr.,
Dir. of Product Development at Nordson Medical, Phillips Medisize and Medtronic, 23 patents, 4 exits
Deepak Kotak, MD
CSO
Deepak Kotak, MD
CSO
AI / Healthtech Entrepreneur,
Medtech VC Investor, formerly
10 yrs Critical Care Physician, Sr. medical & business advisor
Robert Orr
CFO
Robert Orr
CFO
Medtech Entrepreneur,
15 yrs CEO of Life360 Innov., formerly 20 yrs consulting tax/M&A at PwC and Deloitte
Our Mission
Our Mission
We empower healthcare professionals with cutting-edge AI medical technology to optimize heart failure treatment, improve patient outcomes, and reduce healthcare costs — redefining the standard of care for hemodynamic monitoring.
Contact Us
Contact Us
Locations:
Galway, Ireland
Austin, TX, USA
Page updated
Report abuse